Product Images Deflazacort Oral Suspension
View Photos of Packaging, Labels & Appearance
- Tris Chemdraw Structure - deflazacort oral suspension 1
- FigureI - deflazacort oral suspension 10
- FigureJ - deflazacort oral suspension 11
- FigureK - deflazacort oral suspension 12
- FigureL - deflazacort oral suspension 13
- Label - deflazacort oral suspension 14
- FigureA - deflazacort oral suspension 2
- FigureB - deflazacort oral suspension 3
- FigureC - deflazacort oral suspension 4
- FigureD - deflazacort oral suspension 5
- FigureE - deflazacort oral suspension 6
- FigureF - deflazacort oral suspension 7
- FigureG - deflazacort oral suspension 8
- FigureH - deflazacort oral suspension 9
Product Label Images
The following 14 images provide visual information about the product associated with Deflazacort Oral Suspension NDC 27808-249 by Cranbury Pharmaceuticals, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label - deflazacort oral suspension 14

This is a description of Deflazacort Oral Suspension with a concentration of 22.75 mg/mL for oral administration. Each mL contains 2275 mg of deflazacort. The medication is to be stored at 20° to 25°C (68°F to 77°F) with excursions permitted to 15° to 30°C (59°F to 86°F). The package is child-resistant, and it is recommended to close tightly after opening. The manufacturer is Tis Pharma, Inc. based in Monmouth Junction, NJ with additional details provided for usage and storage.*
FigureA - deflazacort oral suspension 2

This text describes a package containing Deflazacort oral suspension in a carton along with a bottle, bottle adapter, and a household cup for dispensing the medication orally.*
FigureD - deflazacort oral suspension 5

This text provides instructions on how to use a bottle adapter. It states to press down on the adapter using both thumbs. This simple and clear description guides the user on how to use the product effectively.*
FigureG - deflazacort oral suspension 8

This text provides guidance on how to measure the dose from the widest part of the plunger. It suggests a method for ensuring accurate dosage administration.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.